Company Analysis

Aurinia Pharmaceuticals Inc (AUPH)

Nasdaq: AUPH · Pharmaceutical Preparations · Edmonton, AB · filing with the SEC since 2014
Grade6.8
◀ Past 8.2● Present 6.8▶ Future 5.5

Who runs Aurinia Pharmaceuticals Inc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Tang Kevin
Chief Executive Officer. First filing Sep 2024, latest Jun 2, 2026, 5 filings in all.
Officers reporting now
8
of 12 people with a filing in the last fifteen months
Directors reporting now
4
29 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Robertson Stephen P.Chief Legal OfficerJan 2021Sep 11, 20262 · $500,000
Tang KevinChief Executive OfficerSep 2024Jun 2, 2026none
Hearne Michael SChief Financial OfficerApr 2026May 20, 2026none
Cole RyanChief Operating OfficerApr 2026May 20, 2026none
Keenan GregSVP, Chief Medical OfficerNov 2024Mar 10, 2026none
Greenleaf PeterChief Executive OfficerJan 2021Mar 3, 2026none
Miller Joseph MChief Financial OfficerJan 2021Mar 3, 2026none
Donley Matthew MaxwellChief Operating OfficerJan 2021Mar 3, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bailey Jeffrey AllendirectorAug 2023Jun 8, 2026none
Goetz KathleendirectorMay 2025Jun 8, 2026none
Johnson Craig AdirectorNov 2024Jun 8, 2026none
Nova Tina SusandirectorMay 2025Jun 8, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Tang Capital Management LLC10% ownerMay 2026Jun 2, 2026none
Earlier names on the record17, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AUPH · research, not advice